Sign In
Buy NTRA
$234.76
+5.96 (+2.60%)
At Close: Jun 23, 2026
Best Momentum Stocks to Buy for October 23rd
11:15am, Wednesday, 23'rd Oct 2024
GPCR, RUSHA and NTRA made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on October 23, 2024.
Court Orders Permanent Injunction Against NeoGenomics' Accused RaDaR Assay, as Case Enters New Phase
04:06pm, Monday, 23'rd Sep 2024
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) and genetic testing, today issued the following statement regarding its ongoing patent infringemen
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced the simultaneous publication of three peer-reviewed papers, crossing
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, announced that new data from the GALAXY arm of the ongoing CIRCULATE-Japan trial was
Natera to Present New Signatera™ Colorectal Cancer Data at ESMO Showing 10X Advantage in Overall Survival
08:22pm, Sunday, 08'th Sep 2024
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced it will present new data on its personalized and tumor-informed molec
The Committee's Comeback Kids: Trade Desk, Sweetgreen, Natera, Samsara, PayPal and Leidos
01:19pm, Thursday, 29'th Aug 2024
The Investment Committee discuss their comeback stocks following the August 5th lows.
Natera to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
09:00am, Wednesday, 28'th Aug 2024
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that members of its leadership team will present at the Morgan Stanle
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
06:40am, Tuesday, 20'th Aug 2024
Cathie Wood of Ark Invest bought millions of dollars worth of shares recently. Amazon was a key purchase across most of her funds.
Natera: Focus On Signatera And H1 2024 Results
04:46pm, Wednesday, 14'th Aug 2024
Natera, Inc. is a diagnostic company focusing on cfDNA tests in women's health, organ health, and oncology. Natera's MRD test, Signatera, demonstrated strong growth, with a 64% increase in processed t
Compared to Estimates, Natera (NTRA) Q2 Earnings: A Look at Key Metrics
08:01pm, Thursday, 08'th Aug 2024
The headline numbers for Natera (NTRA) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates
Natera (NTRA) Reports Q2 Loss, Tops Revenue Estimates
07:26pm, Thursday, 08'th Aug 2024
Natera (NTRA) came out with a quarterly loss of $0.30 per share versus the Zacks Consensus Estimate of a loss of $0.69. This compares to loss of $0.97 per share a year ago.
ATLANTA--(BUSINESS WIRE)--Sharpie® and Paper Mate®, two of the world's leading writing brands, part of Newell Brands' global portfolio, have announced a three-year $1 million partnership with Boys &
Natera (NTRA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
11:07am, Thursday, 25'th Jul 2024
Natera (NTRA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
09:50am, Monday, 22'nd Jul 2024
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Natera to Present at the 28th International Conference on Prenatal Diagnosis and Therapy
07:00am, Wednesday, 03'rd Jul 2024
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) and genetic testing, today announced that its latest research and data on prenatal and reproductiv
